Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Cannabinol

A cannabinoid isolated from the plant Cannabis that is a metabolite of tetrahydrocannabinol (THC), with potential immunosuppressive and anti-inflammatory activities. Cannabinol preferentially binds to the cannabinoid G-protein coupled receptor CB2, which is mainly expressed on a variety of immune cells, such as T cells, B cells, macrophages and dendritic cells. Stimulation of CB2 receptors by cannabinol may both trigger apoptosis in these cells and inhibit the production of a variety of cytokines. Cannabinol exerts minimal affinity for CB1 and has a weak effect on the central nervous system.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Abbreviation:CBN
Chemical structure:3-amyl-1-hydroxy-6,6,9-trimethyl-6H-dibenzo(b,d)pyran
6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search